Short seller Andrew Left has his doubts about Canadian pot stocks, says he's betting against Canopy

Citron Research's Andrew left reiterated his bet against the Canadian cannabis industry, telling CNBC that he's short Canopy Growth and Cronos Group in addition to his already disclosed wager against Tilray.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.